SCHEMBL294103

SCHEMBL294103

CCc1cc(O)c(CC)c(CC)c1CC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 2/20 0.45
ALOX12 P18054 1/20 0.45
BACE1 P56817 1/20 0.39
POLB P06746 3/20 0.38
RECQL P46063 3/20 0.38
ALDH1A1 P00352 3/20 0.38
TDP1 Q9NUW8 3/20 0.38
KDM4E B2RXH2 3/20 0.38
MEN1 O00255 2/20 0.38
MAPT P10636 2/20 0.38
THRB P10828 2/20 0.38
KMT2A Q03164 2/20 0.38
HKDC1 Q2TB90 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
MAPK1 P28482 2/20 0.38
HTT P42858 2/20 0.38
APEX1 P27695 1/20 0.38
CACNA1B Q00975 1/20 0.38
APBA1 Q02410 1/20 0.38
MCL1 Q07820 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30989135 1.00 ALOX15 (0.45) ALOX15ALOX12BACE1POLBRECQL
SCHEMBL10418587 0.87 BACE1 (0.43) ALOX15ALOX12BACE1POLBRECQL
SCHEMBL1179824 0.85 ALOX15 (0.45) ALOX15ALOX12BACE1POLBRECQL
SCHEMBL5586815 0.83 ALOX15 (0.43) ALOX15ALOX12BACE1POLBRECQL
SCHEMBL11528069 0.83 ALOX15 (0.43) ALOX15ALOX12BACE1POLBRECQL
SCHEMBL29668358 0.83 ALOX15 (0.43) ALOX15ALOX12BACE1POLBRECQL
SCHEMBL1760472 0.83 ALOX15 (0.43) ALOX15ALOX12BACE1POLBRECQL
SCHEMBL8754778 0.81 ALOX15 (0.42) ALOX15ALOX12BACE1POLBRECQL
SCHEMBL30523811 0.81 ALOX15 (0.42) ALOX15ALOX12BACE1POLBRECQL
SCHEMBL168554 0.81 GRIN2D (0.36) ALOX15ALOX12POLBHTTESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118355911-A Agricultural composition for preventing and treating tobacco black shank and application thereof 贵州省烟草科学研究院 2024-07-19 CN claimed
CN-111900252-A Flexible TFT device and preparation method thereof 广东省半导体产业技术研究院 2020-11-06 CN claimed
CN-116171988-B Application of 4-propylphenol in soil-borne disease control 山东农业大学 2025-06-24 CN disclosed
CN-119798046-A Method for recovering phenol from waste polycarbonate plastic 东南大学 2025-04-11 CN disclosed
CN-118459321-A Method for obtaining C6 monophenol by selectively hydrogenolyzing lignin 东南大学 2024-08-09 CN disclosed
CN-118355911-A Agricultural composition for preventing and treating tobacco black shank and application thereof 贵州省烟草科学研究院 2024-07-19 CN disclosed
CN-118355911-A Agricultural composition for preventing and treating tobacco black shank and application thereof 贵州省烟草科学研究院 2024-07-19 CN disclosed
CN-118122361-A Method for preparing C2-phenol monomer by hydrogenolysis of lignin by using nickel-based alkaline carrier catalyst 东南大学 2024-06-04 CN disclosed
CN-118122361-A Method for preparing C2-phenol monomer by hydrogenolysis of lignin by using nickel-based alkaline carrier catalyst 东南大学 2024-06-04 CN disclosed
CN-116171988-A Application of 4-propylphenol in soil-borne disease control 山东农业大学 2023-05-30 CN disclosed
CN-113057162-B Application of 4-ethylphenol in prevention and treatment of tobacco black shank 山东农业大学 2022-02-08 CN disclosed
EP-2287162-A1 Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of cns disorders Otsuka Pharmaceutical Co., Ltd. (JP) 2011-02-23 EP disclosed
EP-2287161-A1 Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of cns disorders Otsuka Pharmaceutical Co., Limited (JP) 2011-02-23 EP disclosed
EP-1919907-B1 HETEROCYCLIC COMPOUND OTSUKA PHARMA CO LTD (JP) 2011-02-23 EP disclosed
EP-2284169-A1 Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of CNS disorders Otsuka Pharmaceutical Co., Limited (JP) 2011-02-16 EP disclosed
US-20090264404-A1 Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of cns disorders OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2009-10-22 US disclosed
CN-101258147-A 4-piperazin-1-yl-4-benzo [ B ] thiophene derivatives for the treatment of CNS disorders OTSUKA PHARMA CO LTD (JP) 2008-09-03 CN disclosed
EP-1919907-A2 HETEROCYCLIC COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2008-05-14 EP disclosed
WO-2007026959-A2 DERIVATIVES OF 4-PIPERAZIN-1-YL-4-BENZ0 [B] THIOPHENE SUITABLE FOR THE TREATMENT OF CNS DISORDERS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-03-08 WO disclosed
US-3945891-A Distillation process for purification of triaryl phosphate esters FMC CORPORATION (US) 1976-03-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090264404-A1 Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of cns disorders GRIN2C, GRIN2B, PMP22 ALOX15 3509/4885ALOX12 3330/4885BACE1 1859/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.